MARKET

IPDQF

IPDQF

Impedimed
OTCPK
0.0039
NaN%
Closed 09:30 10/23 EDT
OPEN
--
PREV CLOSE
0.0039
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0066
52 WEEK LOW
0.0033
MARKET CAP
14.28M
P/E (TTM)
-0.4815
1D
5D
1M
3M
1Y
5Y
1D
ImpediMed Discloses Director Share Transfer Following Financial Settlement
TipRanks · 3d ago
Impedimed Seeks ASX Quotation for Additional Ordinary Shares
TipRanks · 10/14 03:37
ImpediMed Director Erik Anderson Significantly Increases Shareholding
TipRanks · 09/30 04:08
ImpediMed Keeps Existing Structure for Attaching and Follow-On Options After ASX Ruling
TipRanks · 09/23 23:16
ImpediMed Sets November Date for 2026 AGM and Board Nomination Deadline
TipRanks · 09/11 02:17
Analysts Offer Insights on Healthcare Companies: Impedimed Limited (OtherIPDQF) and Intuitive Surgical (ISRG)
TipRanks · 08/31 00:40
Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)
TipRanks · 08/27 23:40
ImpediMed lodges 2026 Corporate Governance Statement and Appendix 4G
TipRanks · 08/27 01:20
More
About IPDQF
ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. Its SOZO Applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.

Webull offers ImpediMed Ltd stock information, including OTCPK: IPDQF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IPDQF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IPDQF stock methods without spending real money on the virtual paper trading platform.